Hemab Therapeutics Holdings COAG
NASDAQ COAG
$40.86 +1.48 (+3.76%)
At close: Nov 13, 2026 · 4:00 PM EST

Hemab Therapeutics Holdings (COAG) Assets (2024 - 2026)

Updated

Hemab Therapeutics Holdings' Assets was $442.71 million in Q3 2026, down 5.4% from the prior quarter.

Analysis

Hemab Therapeutics Holdings (COAG) Assets (2024 - 2026) Analysis & Trends

At the end of FY2025, Assets at Hemab Therapeutics Holdings came in at $194.78 million, up 102.3% from FY2024.

  • In earlier years, Assets was $96.28 million in FY2024.
  • Quarterly Assets has moved between $96.28 million (Q4 2024) and $467.78 million (Q2 2026) over five years.
  • Per Business Quant data, COAG's Assets in the three quarters before Q3 2026 was $467.78 million (Q2 2026), $175.26 million (Q1 2026) and $194.78 million (Q4 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Assets (Qtr)
1 Eli Lilly 1,359.75 Bn 1,333.37 Bn 20.46 Bn 148.07 Bn
2 Johnson & Johnson 688.76 Bn 608.62 Bn 17.30 Bn 197.43 Bn
3 AbbVie 521.69 Bn 489.75 Bn 13.12 Bn 147.68 Bn
4 Merck 364.31 Bn 327.31 Bn 13.19 Bn 132.77 Bn
5 Novartis Ag 306.35 Bn 279.93 Bn - -
6 Astrazeneca 285.96 Bn 259.56 Bn 13.26 Bn 119.92 Bn
7 Amgen 251.88 Bn 203.53 Bn 7.58 Bn 96.05 Bn
8 Gilead Sciences 208.59 Bn 183.61 Bn 6.73 Bn 51.41 Bn
9 Pfizer 164.73 Bn 112.38 Bn 12.56 Bn 205.00 Bn
10 Hemab Therapeutics Holdings 1.91 Bn 672.70 Mn - 442.71 Mn
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2026 442.71 Mn
Jun 30, 2026 467.78 Mn
Mar 31, 2026 175.26 Mn
Dec 31, 2025 194.78 Mn
Dec 31, 2024 96.28 Mn
API Access

Hemab Therapeutics Holdings Assets API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=assets&ticker=COAG&period=max&api_key=YOUR_API_KEY